Pre-ciliated tubal epithelial cells are prone to initiation of high-grade serous ovarian carcinoma

Andrea Flesken-Nikitin & Alexander Yu Nikitin et al. · 2024-10-05

The distal region of the uterine (Fallopian) tube is commonly associated with high-grade serous carcinoma (HGSC), the predominant and most aggressive form of ovarian or extra-uterine cancer. Specific cell states and lineage dynamics of the adult tubal epithelium (TE) remain insufficiently understood, hindering efforts to determine the cell of origin for HGSC. Here, we report a comprehensive census of cell types and states of the mouse uterine tube. We show that distal TE cells expressing the stem/progenitor cell marker Slc1a3 can differentiate into both secretory (Ovgp1+) and ciliated (Fam183b+) cells. Inactivation of Trp53 and Rb1, whose pathways are commonly altered in HGSC, leads to elimination of targeted Slc1a3+ cells by apoptosis, thereby preventing their malignant transformation. In contrast, pre-ciliated cells (Krt5+, Prom1+, Trp73+) remain cancer-prone and give rise to serous tubal intraepithelial carcinomas and overt HGSC. These findings identify transitional pre-ciliated cells as a cancer-prone cell state and point to pre-ciliation mechanisms as diagnostic and therapeutic targets.
Funding
Cancer-prone cell states of the fallopian tubal epitheliumOrigins of Ovarian CarcinomaOvarian Cancer Research Fund (Ovarian Cancer Research Fund, Inc.) Grant 327516PathologyEndometrial epithelial stem cells and cancerCancer-prone cell states of the fallopian tubal epitheliumZeiss LSM710 Confocal Microscope for Shared Imaging FacilityNSF | Directorate for Education & Human Resources | Division of Graduate Education (DGE) Grant DGE-2139899Origins of Ovarian CarcinomaEndometrial epithelial stem cells and cancerOrigins of Ovarian CarcinomaCancer-prone cell states of the fallopian tubal epitheliumEndometrial epithelial stem cells and cancerU.S. Department of Health & Human Services | NIH | National Cancer Institute FundingSandra Atlas Bass Endowment for Cancer Research FundingNSF | Directorate for Education & Human Resources | Division of Graduate Education Grant DGE-2139899

U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI)

CA260115

NCI NIH HHS

R01 CA182413

NCI NIH HHS

P30 CA008748

NCI NIH HHS

R01 CA248524

NCI NIH HHS

R01 CA260115

NCRR NIH HHS

S10 RR025502

U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI)

CA182413

U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI)

CA248524

U.S. Department of Health & Human Services | NIH | National Cancer Institute

CA182413

U.S. Department of Health & Human Services | NIH | National Cancer Institute

CA260115

U.S. Department of Health & Human Services | NIH | National Cancer Institute

CA248524